USFDA

Lupin gets 3 observations from USFDA for its Tarapur facility

Read more

Dr Reddy’s halts worldwide supply of ranitidine

Read more

Dr Reddy’s launches heartburn capsules in US market

Read more

Aurobindo Pharma recalls over 2k bottles of lipid-lowering tablets from US

Read more

USFDA issues response letter for new drug application for insulin glargine: Biocon

Read more

USFDA pulls up Lantech Pharma for manufacturing violations at Andhra plant

Read more

Glenmark Pharma gets USFDA nod for skin treatment ointment

Read more

FDA gives fast track status to AstraZeneca’s diabetes drug Farxiga

Read more

Strides Pharma acquires USFDA approved manufacturing facility in US

Read more

USFDA clears Indoco’s Goa Plant II and III

Read more